Aurobindo receives FDA approval for mycophenolic acid DR tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application mycophenolic acid DR Tablets USP, 180mg & 360mg.